Moderna files for full FDA approval of its COVID-19 vaccine

Moderna today asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older. So far, 124 million doses of the Moderna vaccine have been administered in the U.S. Moderna’s request for a priority review of its Biologics License Application includes data submitted on a rolling basis culled from its ongoing phase 3 clinical trial. Moderna is currently tracking about three weeks behind Pfizer, whose application for full FDA approval of its own COVID-19 vaccine was submitted May 7.
Related News Articles
Headline
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Headline
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food…
Headline
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament…
Headline
The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months…
Headline
The Food and Drug Administration will end 22 COVID-19-related policies when the public health emergency ends May 11 and allow 22 to continue for 180 days,…
Headline
Qualified family members of health care workers whose lives were lost to COVID-19 may apply through April 20 at 3 p.m. CT for a Brave of Heart Scholarship. The…